Be Ahead With Economy And Policy Updates
Sun Pharma’s proposed 11.75‑billion‑dollar acquisition of US‑based Organon is a coming‑of‑age moment for Indian pharma on the global stage. It will put India’s…
Gurugram: Jagsonpal Pharmaceuticals Limited (BSE: 507789, NSE: JAGSNPHARM) today announced the audited financial results for the quarter and year ended March…
New Delhi: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its…
Ahmedabad: Zydus Lifesciences Limited (“Zydus”), an innovation-led global lifesciences company, announced that it has received permission to conduct two Phase…
New Delhi: The National Institute of Pharmaceutical Education and Research (NIPER), Hajipur has signed a Memorandum of Understanding (MoU) with the Indian…
New Delhi: Aurobindo Pharma Limited has announced that it has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and…
Bengaluru: Aster DM Healthcare, one of the largest integrated healthcare providers in India, has invested Rs — Aster DM Healthcare expands ‘Women & Children’…
New Jersey: Glenmark Pharmaceuticals Limited (Glenmark) has received final approval from the United States Food & Drug Administration (U.S — Glenmark…
Ahmedabad: Zydus Lifesciences Limited (“Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Dapagliflozin…
New Delhi: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its…
Newsletter
GAIL Appoints Manoj Kumar Sharma as Director (Projects)
PM Modi: Carbon Emissions Responsibility Wrongly Placed on Developing Countries
THDC India Wins ‘Green Future Leadership Award’
IREDA CMD Dr. Bijay Kumar Mohanty Emphasises Asset Quality and Good Governance Core to Growth
Maruti Suzuki Introduces Automatic S-CNG Swift, Dzire and Baleno
Hindustan Zinc adds 32 Mnt ore in FY26 as exploration success rate crosses 88%